HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Reyes Selected Research

Neoplasms (Cancer)

1/2020The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy.
1/2020The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy.
1/2020Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study.
6/201810 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy
6/2017[Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.]
1/2016Efficacy of Using Sequential Primary Circulating Prostate Cell Detection for Initial Prostate Biopsy in Men Suspected of Prostate Cancer.
1/2016Head to Head Comparison of the Chun Nomogram, Percentage Free PSA and Primary Circulating Prostate Cells to Predict the Presence of Prostate Cancer at Repeat Biopsy.
1/2015Prostate cancer screening in the fit Chilean elderly: a head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate cells to detect prostate cancer at initial biopsy.
1/2015Possible Role of HER-2 in the Progression of Prostate Cancer from Primary Tumor to Androgen Independence.
1/2015Comparison of the Formula of PSA, Age, Prostate Volume and Race Versus PSA Density and the Detection of Primary Malignant Circulating Prostate Cells in Predicting a Positive Initial Prostate Biopsy in Chilean Men with Suspicion of Prostate Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Reyes Research Topics

Disease

32Prostatic Neoplasms (Prostate Cancer)
09/2020 - 06/2010
16Neoplasms (Cancer)
01/2020 - 01/2003
9Residual Neoplasm
07/2021 - 12/2017
8Neoplasm Metastasis (Metastasis)
07/2021 - 01/2018
4Neoplasm Micrometastasis
01/2020 - 06/2010
4Infections
11/2018 - 10/2002
3Disease Progression
01/2018 - 01/2012
3Necrosis
07/2010 - 04/2004
3Fibrosis (Cirrhosis)
07/2010 - 04/2004
2Margins of Excision
01/2016 - 01/2015
2Dengue (Dengue Fever)
09/2015 - 03/2014
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2014 - 07/2013
2Sepsis (Septicemia)
03/2013 - 06/2012
1Extranodal Extension
01/2015
1Skin Neoplasms (Skin Cancer)
04/2013
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
03/2013
1Prostatitis
01/2013
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2012
1Thrombosis (Thrombus)
03/2012
1Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
01/2012
1Renal Cell Carcinoma (Grawitz Tumor)
01/2012
1Vasculitis (Vasculitides)
01/2012
1Septic Shock (Toxic Shock Syndrome)
03/2011
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
07/2010
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2010
1Portal Hypertension
07/2010
1Brucellosis (Malta Fever)
07/2010
1Chronic Obstructive Pulmonary Disease (COPD)
03/2006
1Vitiligo
03/2006
1Bacterial Infections (Bacterial Infection)
08/2005
1Inflammation (Inflammations)
08/2005
1Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
04/2004
1Chemotherapy-Induced Febrile Neutropenia
01/2003
1Fever (Fevers)
01/2003
1Neutropenia
01/2003
1Chronic Hepatitis C
10/2002

Drug/Important Bio-Agent (IBA)

20cytidylyl-(3'-5')-cytidine (CpC)IBA
07/2021 - 06/2010
6Biological ProductsIBA
07/2021 - 07/2013
6Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 04/2013
6CytokinesIBA
09/2015 - 08/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2011 - 04/2004
3Biomarkers (Surrogate Marker)IBA
11/2019 - 03/2013
3Interleukin-6 (Interleukin 6)IBA
03/2014 - 06/2006
3Immunoferon (AM3)IBA
07/2010 - 03/2006
3Immunologic Factors (Immunomodulators)IBA
07/2010 - 03/2006
2LigandsIBA
09/2015 - 03/2014
2Cytokine Receptors (Cytokine Receptor)IBA
09/2015 - 03/2014
2EnzymesIBA
01/2013 - 07/2010
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2012 - 09/2010
2Interferon-gamma (Interferon, gamma)IBA
07/2010 - 08/2005
1Dihydrotachysterol (AT 10)IBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
11/2018
1Indicators and Reagents (Reagents)IBA
06/2017
1Capsules (Microcapsules)IBA
01/2016
1AndrogensIBA
01/2015
1Interleukin-17 (Interleukin 17)IBA
03/2014
1Interleukin-12 (IL 12)IBA
03/2014
1Interleukin-1 (Interleukin 1)IBA
03/2014
1TNF-Related Apoptosis-Inducing LigandIBA
03/2014
1Interleukin-1 Receptor-Like 1 ProteinIBA
03/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2013
1SelectinsIBA
03/2013
1E-SelectinIBA
03/2013
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2012
1Bevacizumab (Avastin)FDA Link
03/2012
1Heparin (Liquaemin)FDA LinkGeneric
03/2012
1AnticoagulantsIBA
01/2012
1Diphosphonates (Bisphosphonates)IBA
01/2012
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2012
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
03/2011
1InterleukinsIBA
03/2011
1Proteins (Proteins, Gene)FDA Link
09/2010
1Messenger RNA (mRNA)IBA
07/2010
1phorbolIBA
07/2010
1Interleukin-4 (Interleukin 4)IBA
07/2010
1Interleukin-10 (Interleukin 10)IBA
07/2010
1Interleukin-2 (IL2)IBA
07/2010
1ImmunosorbentsIBA
07/2010
1Hydroxyproline (4 Hydroxyproline)IBA
07/2010
1Myristic Acid (Tetradecanoic Acid)IBA
07/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
07/2010
1Interleukin-12 Subunit p40IBA
07/2010
1alpha 1 Chain Collagen Type IIBA
07/2010
1Type I Tumor Necrosis Factor ReceptorsIBA
06/2006
1Carrier Proteins (Binding Protein)IBA
04/2004
1NorfloxacinFDA Link
04/2004
1InterferonsIBA
10/2002
1Interferon-alpha (Interferon Alfa)IBA
10/2002

Therapy/Procedure

21Prostatectomy (Retropubic Prostatectomy)
07/2021 - 01/2013
5Therapeutics
06/2019 - 01/2003
2Radiotherapy
01/2020 - 01/2018
1Time-to-Treatment
01/2020
1Nephrectomy
01/2012
1Aftercare (After-Treatment)
07/2010
1PUVA Therapy
03/2006
1Drug Therapy (Chemotherapy)
01/2003